Publikationen von 0000-0002-8740-3106
(ORCID: 0000-0002-8740-3106)

Lind, Lisa-Marie, Fischl, Anna, Goettl, Elisabeth, Herr, Wolfgang, Kaiser, Ulrich, Koelbl, Oliver, Linker, Ralf , Maurer, Julia , Riemenschneider, Markus J. , Schmidt, Nils-Ole, Proescholdt, Martin A. , Pukrop, Tobias , Hau, Peter , Rechenmacher, Michael und Bumes, Elisabeth (2026) Palliative care interventions and outcome in patients with glioblastoma – a retrospective, single-center study. BMC Palliative Care 25 (1).

Steinberg, Tim Johannes, Mayer, Lucie, Freudenstein, David, Müller, Karolina , Angstwurm, Klemens , Linker, Ralf A. und Lee, De-Hyung (2025) Differential diagnoses of MS in clinical practice: incidence and methods for differential diagnosis. Frontiers in Neurology 16.

Schlachetzki, Felix , Feistenauer, Ina, Ertl, Michael, Kilic, Mustafa , Aden, Fabian, Pollinger, David, Helbig, Horst, Wendl, Christina, Pfister, Karin, Krenkel, Lars, Gamulescu, Maria Andreea, Linker, Ralf A. und Wilfling, Sibylle (2025) Retinal ischemia due to different stages of atherosclerosis - insights from a retrospective study on central retinal artery occlusion. Neurological Research and Practice 7 (1).

Haedenkamp, Tareq M. , Götz, Linda, Ansafi, Tananeh, Gerken, Michael, Klinkhammer-Schalke, Monika, Fischl, Anna, Riemenschneider, Markus J. , Maurer, Julia , Proescholdt, Martin A. , Kölbl, Oliver, Schmidt, Nils Ole , Linker, Ralf A. , Bumes, Elisabeth und Hau, Peter (2025) Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma – a retrospective cohort study. Journal of Neuro-Oncology 175 (1), S. 345-355.

Scheu, Katrin, Vandieken, Edith, Hense, Katharina , Rosengarth, Katharina, Haedenkamp, Tareq M. , Lenglinger, Markus, Bumes, Elisabeth , Linker, Ralf , Proescholdt, Martin , Schmidt, Nils Ole , Riemenschneider, Markus J. , Wendl, Christina, Wiesinger, Isabel und Hau, Peter (2025) MRI-defined patterns of infiltration and outcome in patients with glioblastoma. Neuro-Oncology Advances 7 (1).

Kvartskhava, Tamar, Freudenstein, David, Sarmiento, Nicolas, Angstwurm, Klemens , Linker, Ralf und Lee, De-Hyung (2025) Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences 475, S. 123577.

Träger, Constantin, Kaiser, Maria, Freudenstein, David, Heckscher, Simon, Dettmer, Katja , Oefner, Peter J. , Liebisch, Gerhard , Hiergeist, Andreas , Gessner, André , Lee, De-Hyung, Angstwurm, Klemens , Linker, Ralf A. und Haase, Stefanie (2025) A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals. eBioMedicine 116, S. 105743.

Wecker, Sophie, Freudenstein, David, Ganser, Iris, Angstwurm, Klemens , Lee, De-Hyung und Linker, Ralf A. (2024) The impact of different lifestyle factors on disability in multiple sclerosis at older ages: a monocentric retrospective study. Therapeutic Advances in Neurological Disorders 17.

Haase, Stefanie, Kuhbandner, Kristina, Mühleck, Florian, Gisevius, Barbara, Freudenstein, David, Hirschberg, Sarah, Lee, De-Hyung, Kuerten, Stefanie, Gold, Ralf, Haghikia, Aiden und Linker, Ralf A. (2024) Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration. Frontiers in Immunology 15.

Reinhardt, Caroline , Angstwurm, Klemens , Freudenstein, David, Lee, De-Hyung, Wendl, Christina und Linker, Ralf A. (2024) Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool. Neurological Research and Practice 6 (1).

Haase, Stefanie und Linker, Ralf A. (2021) Inflammation in multiple sclerosis. Therapeutic Advances in Neurological Disorders 14, S. 175628642110076.

Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf , Mäurer, Mathias, Aktas, Orhan, Baum, Karl, Berghoff, Martin, Bittner, Stefan, Chan, Andrew, Czaplinski, Adam, Deisenhammer, Florian, Di Pauli, Franziska, Du Pasquier, Renaud, Enzinger, Christian, Fertl, Elisabeth, Gass, Achim, Gehring, Klaus, Gobbi, Claudio, Goebels, Norbert, Guger, Michael, Haghikia, Aiden, Hartung, Hans-Peter, Heidenreich, Fedor, Hoffmann, Olaf, Kallmann, Boris, Kleinschnitz, Christoph , Klotz, Luisa, Leussink, Verena I., Leutmezer, Fritz, Limmroth, Volker, Lünemann, Jan D., Lutterotti, Andreas, Meuth, Sven G., Meyding-Lamadé, Uta, Platten, Michael, Rieckmann, Peter, Schmidt, Stephan, Tumani, Hayrettin, Weber, Frank, Weber, Martin S., Zettl, Uwe K., Ziemssen, Tjalf und Zipp, Frauke (2021) Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic Advances in Neurological Disorders 14, S. 175628642110396. Volltext nicht vorhanden.

Mäurer, Mathias, Tiel-Wilck, Klaus, Oehm, Eckard, Richter, Nils, Springer, Michael, Oschmann, Patrick, Manzel, Arndt, Hieke-Schulz, Stefanie, Zingler, Vera, Kandenwein, Julia A., Ziemssen, Tjalf und Linker, Ralf A. (2019) Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 12, S. 175628641989207. Volltext nicht vorhanden.